Healthcare

Owkin Federated AI

Federated AI for medical research without data sharing

Visit Owkin Federated AI
4.6rating1 viewsPricing · PaidHot
The Falcoscan Intel Panel/Owkin Federated AI · Healthcare
Live market data
Opportunity
86
Strong/ 100
Saturation
8
Open/ 100
Wrapper Risk
5
Open/ 100
Signal
Hot
Market trend
Rating
4.6
of 5 · 1 views
The Brief

What Owkin Federated AI does and why it matters

Owkin enables hospitals to collaborate on AI research without sharing sensitive patient data using federated learning. The platform trains models on distributed datasets across institutions while keeping data local.

Builder’s Brief

Owkin Federated AI is a healthcare tool on Falcoscan. Federated AI for medical research without data sharing. Falcoscan rates Owkin Federated AI with an Opportunity score of 86/100, a Saturation score of 8/100, and a Wrapper-risk score of 5/100. Market signal: hot. Owkin Federated AI is founded in 2016, currently at Series_a stage. Pricing: Paid. Rating 4.6/5 across 1 tracked views.

What it ships with

Capabilities & who uses it

The capabilities Owkin Federated AI exposes to builders and the verticals it currently serves.

AI Capabilities
ClassificationPredictive AnalyticsData Extraction
Industry Verticals
PharmaceuticalHealthcareResearch
Similar tools · Healthcare

Tools builders compare to Owkin Federated AI

The top-rated healthcare alternatives tracked on Falcoscan. Ranked by user rating within the category.

See the Healthcare market
Healthcare
DeepMind AlphaFold

AI protein structure prediction for drug discovery

4.9Opp 88
Free
Healthcare
Viz.ai Stroke AI

AI triage and coordination platform for stroke care

4.8Opp 88
Paid
Healthcare
Nuance DAX Copilot

AI clinical documentation assistant for physicians

4.8Opp 90
Paid
Healthcare
Viz.ai AI Stroke Response

AI stroke detection and care coordination platform

4.8Opp 90
Paid
Healthcare
Tempus AI Diagnostics

AI liquid biopsy analysis for early cancer detection

4.8Opp 88
Paid
Healthcare
Veracyte Genomics AI

AI genomic testing for cancer diagnosis and treatment selection

4.7Opp 86
Paid
Back to Browse